Home
Conditions
Metastatic Breast Cancer

Clinical trial condition

Metastatic Breast Cancer

Explore clinical trials studying Metastatic Breast Cancer. Study availability and eligibility vary by location and protocol.

643 public trials 134 recruiting studies

Refine in advanced search Browse all conditions

Metastatic Breast Cancer trial results

Recruiting

Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort

NCT05693766

Conditions: Breast Diseases, Breast Neoplasms, Invasive Mammary Carcinoma, +5 more
Locations: University of Alabama Birmingham Birmingham, Alabama, United States

Vanderbilt University/Ingram Cancer Center Nashville, Tennessee, United States

UT Southwestern Medical Center Dallas, Texas, United States

View Trial Details

Recruiting

Feasibility of Symptom Management for Patients With Metastatic Breast Cancer to Increase Exercise

NCT07313306

Conditions: Behavior, Breast Cancer, Breast Diseases, +7 more
Locations: Lineberger Comphrehensive Cancer Center at University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States

View Trial Details

Recruiting

Assessement of Potential Interest of [68Ga]Ga-PentixaFor PET/CT in Metastatic Triple Negative Breast Cancer Patients

NCT06962163

Conditions: Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +5 more
Locations: Institut de cancerologie de l'Ouest Saint-Herblain, France

View Trial Details

Recruiting

Phase II Single Arm Trial of Low Dose Capecitabine in Patients With Advanced Breast Cancer

NCT06105684

Conditions: Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

View Trial Details

Recruiting

A Phase Ib/II Study to Evaluate Multiple Combination Therapies of FWD1802 in Patients With ER+/HER2- BC

NCT07002177

Conditions: Breast Cancer Stage I, Breast Cancer Stage II, Breast Diseases, +8 more
Locations: Fudan University Shanghai Cancer Center, Shanghai Shanghai, China

View Trial Details

Recruiting

Toxicity Markers to Trastuzumab-Deruxtecan (T-DXd) In Patients With Advanced Breast Cancer

NCT07049133

Conditions: Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations: European Institute of Oncolgy Milan, Italy

View Trial Details

Recruiting

Patritumab Deruxtecan (U3-1402) in Unresectable Locally Advanced or Metastatic Breast Cancer

NCT04965766

Conditions: Advanced Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations: Centre Georges François Leclerc Dijon, France

CHU de Limoges Limoges, France

Centre Léon Bérard Lyon, France

Institut Paoli Calmettes Marseille, France

View Trial Details

Recruiting

Prospective Registry of ADC as First- and Second-line Treatment for Breast Cancer

NCT06774027

Conditions: Breast Diseases, Breast Neoplasms, HER2 Negative Breast Carcinoma, +10 more
Locations: University of California, San Francisco San Francisco, California, United States

View Trial Details

Recruiting

BettER: Biomarker Driven Early Therapeutic Selection in Patients With HR+ HER2- Metastatic or Unresectable Breast Cancer

NCT05977036

Conditions: Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +5 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Recruiting

Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer

NCT06409390

Conditions: Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Metastatic Breast Cancer

Metastatic Breast Cancer trial results

Related conditions